The city of Baltimore is suing Eli Lilly, Novo Nordisk and CVS Caremark, alleging that the companies harmed the city and its citizens by conspiring to inflate the price of insulin. Mayor Brandon Scott and the Baltimore City Council filed the lawsuit in the U.S. District Court of Maryland.

The plaintiffs allege that the increased prices make insurance more expensive and put a strain on emergency services and medical facilities because people were rationing their medications.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employee Participation
Employee-Paid
Employer-Paid